|
End-of-day quote
Mexican S.E.
2026-09-24
|
5-day change | 1st Jan Change | ||
| 19.50 MXN | +5.75% |
|
+14.24% | -22.31% |
| 09-14 | Ocugen Insider Sold Shares Worth $589,110, According to a Recent SEC Filing | MT |
| 09-01 | Ocugen Doses First Patient in Trial of Potential Eye Disease Drug | MT |
Chart: Technical Analysis
Mexican S.E.MXN
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| OCGN | Delayed | |
Tradegate
| 2H51 | Real-time | |
|
CBOE
| OCGN | Real-time | |
|
Boerse Muenchen
| 2H51 | Real-time | |
|
Börse Stuttgart
| 2H51 | Delayed | |
|
Deutsche Boerse AG
| 2H51 | Delayed | |
|
Mexican S.E.
| OCGN * | End-of-day quote |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- OCGN Stock
- OCGN * Stock
- Charts Ocugen, Inc.
Select your edition
All financial news and data tailored to specific country editions
